The plant will manufacture various human vaccines such as recombinant hepatitis B, measles, diphtheria, pertussis and tetanus. In addition, the plant has the capability to produce new combination vaccines.
It can simultaneously manufacture 200 million doses of each vaccine per annum. Amrita Patel, chairman, NDDB, said:
